Updated consensus statement for pulmonary rehabilitation of patients with coronavirus disease 2019 (2023)

作     者：Wang Wenqiao Wang Ye Li Danye Ma Xinqi Dong Tairan Zhao Qing Zhao Hongmei Wang Chen 

作者机构：National Center for Respiratory Medicine State Key Laboratory of Respiratory Health and Multimorbidity National Clinical Research Center for Respiratory Diseases Institute of Respiratory Medicine Chinese Academy of Medical Sciences Department of Pulmonary and Critical Care Medicine Center of Respiratory Medicine China-Japan Friendship Hospital Beijing China Institute of Basic Medical Sciences Peking Union Medical College Chinese Academy of Medical Sciences Beijing China 

出 版 物：《中华医学杂志(英文版)》 (Chinese Medical Journal)

年 卷 期：2024年第137卷第21期

页      面：2526页

核心收录：

学科分类：1004[医学-公共卫生与预防医学(可授医学、理学学位)] 100401[医学-流行病与卫生统计学] 10[医学] 

基　　金：Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences (CIFMS)(No. 2021-I2M-1-056) National High Level Hospital Clinical Research Funding(No. 2022-NHLHCRF-LX-01) 

摘      要：Self-management of symptoms is recommended in older (age ≥ 65 years) patients with COVID-19 to improve their health-related quality of life. 1a A 14. Isolation and protection strategies In accordance with the recent approach to infectious disease management, isolation, protection strategies, and treatment location during pulmonary rehabilitation are not covered by the updated guideline. The target of rehabilitation assessment should also be defined (dyspnea; health-related quality of life; somatic, pulmonary, and respiratory muscle functions; fatigue; ability to perform activities of daily living; comorbidities). Comprehensive pulmonary rehabilitation is recommended for patients with COVID-19 for alleviating their symptoms and improving their health-related quality of life.